Facial asymmetry is the baseline condition of the human face, not a finding, and treating it as an exception is how injectors end up defending outcomes they did not cause. Melissa Pulcini-Buttine, PA has a phrase she uses with patients and trainees alike: "Anatomy varies from person to person. Even our sides vary. So I always say our faces, if you split it in half, they're sisters, not twins."
The phrase is doing two jobs. It is an anatomical statement — the two halves are related, not identical — and it is a consultation script, which is why it earns a place in practice rather than just in teaching. This piece is about both: what is actually asymmetric and how you assess it, how that changes the plan, and how to raise it with a patient before you treat rather than after they notice.
How asymmetric, in numbers
Asymmetry is easy to assert and worth quantifying, because the magnitudes are larger than most injectors assume.
More than 88 percent of the population has asymmetric brow positions, and this is documented well enough that the consensus literature treats accounting for it as mandatory in any surgical or non-surgical intervention. Around 5 percent of patients treated strictly according to package-insert protocols require a further touch-up to correct brow asymmetry (Aesthetic Surgery Journal Open Forum 2025;7:ojaf032).
The muscles underneath are asymmetric too, and by more than the face suggests. High-frequency ultrasound of the frontalis, procerus, corrugator supercilii and orbicularis oculi in 127 healthy adults found relative side-to-side asymmetry coefficients reaching 40 percent for both muscle thickness and depth from the epidermis, with several individual muscles reaching 50 percent (Toxins 2025;17(12):595).
One further detail from that study is the most practically important and the least quoted: no significant directional asymmetry was found. The differences are large, but they do not systematically favour one side across the population. There is no "usually the right is bigger" rule to fall back on. Which side differs, and in which direction, is a property of the individual patient — which means it has to be assessed rather than assumed, every time.
Three asymmetries, assessed three different ways
The word "asymmetry" collapses three independent findings. They do not travel together, and each needs its own examination.
Position. Where the structures sit at rest — brow height, brow shape, commissure height, the set of the lower lip. Assessed with the patient still, ideally with a horizontal reference in frame, and captured photographically.
Morphology. How big the muscles are and how deep they lie. This is the layer you cannot see and cannot palpate reliably. Without imaging you are inferring it, and the honest position is that a 40 percent difference in depth between two sides is invisible to inspection. What you can do is treat the inference as a reason for caution about applying an identical depth bilaterally, particularly in regions where depth decides which muscle you reach.
Strength and dynamics. Which side pulls harder, further and faster. This is assessed only on animation, and it is the asymmetry most amenable to neurotoxin because it is the one neurotoxin acts on. Melissa's example is specific: "Sometimes they're asymmetrical, and this side pulls down more than this side. And I can compensate for that with the amount of injections that I do, or the units."
A patient can have symmetric brow position at rest with markedly asymmetric elevation on animation, or the reverse. Recording one and assuming the other is how baseline findings get missed.
The planning consequence
If asymmetry is the norm, then symmetric dosing is a choice that needs justifying rather than a default. Three principles follow.
Dose the finding, not the region. Where one side is demonstrably stronger, treating it identically to the weaker side preserves the asymmetry — or converts it into a different one, because the weaker side has proportionally more of its function removed. Melissa's lever is unit distribution and the number of points.
Do not chase full correction. The instinct to fully neutralise the dominant side is the source of more iatrogenic asymmetry than the original finding. A muscle treated to a substantially higher dose does not merely weaken more; its effect persists longer, so an over-corrected asymmetry outlasts the treatment that was supposed to fix it and reappears in the opposite direction as the lighter side recovers first. Correction toward symmetry, deliberately incomplete, then reviewed, is the durable approach — and it is one of the clearest arguments for a two-week reassessment visit in an asymmetric face.
Establish what toxin can reach. Dynamic asymmetry is treatable because it is muscular. Asymmetry arising from skeletal structure, from differential volume loss, or from fixed dermal creases is not, and no dose adjusts it. The static-versus-dynamic boundary is covered in dynamic vs static wrinkles, and the volumetric contribution in facial volume loss. Attempting to fix a structural asymmetry with a muscular tool produces a patient who is neither symmetric nor satisfied.
The consultation: name it first, once
This is where the "sisters, not twins" phrase pays for itself, and the timing of it matters more than the wording.
Raise it before treatment, not after. Every injector eventually has the conversation in which a patient points out an asymmetry at the two-week review and asks what happened. That conversation is unwinnable if the first time the asymmetry was mentioned is after you injected — not because you are wrong, but because you are now describing a pre-existing finding at exactly the moment you have a motive to. Raised at consultation it is a professional observation. Raised at review it is an excuse.
Ready to put this into practice?
Explore Empire's hands-on, CME-accredited Aesthetic & Injectable Training courses — live patients, expert faculty, and ongoing mentorship.
Show it in the mirror once, then move on. Have the patient animate while you point out the difference — which brow travels further, which side of the frown pulls harder. Demonstrating a finding converts it from an assertion into something the patient has seen for themselves.
Then stop. This is the part that gets done badly. A patient who has just been given an itemised inventory of every asymmetry in their face has been handed a set of concerns they did not arrive with, and some of them will not put it down. Name it as a universal feature of human faces, identify the one or two differences relevant to the plan, state the goal, and change the subject.
State the goal as balance, not identity. The realistic aim is improved symmetry, not matched halves, and saying so is both honest and protective. Sisters, not twins, is exactly the right level of precision for that sentence.
Record it. Baseline asymmetry noted in the chart with animated photography is a finding. The same asymmetry discovered after treatment is an allegation. Empire's guidance on what to include in botox consent forms covers the documentation framework; the specific addition here is that pre-treatment photographs should include animation, not only repose, because the dynamic asymmetry is the one the patient will notice.
The patient who wants symmetry
Occasionally a patient responds to this conversation by asking for the halves to be made to match. It is worth having an answer ready.
The answer is that matching is not achievable, and that pursuing it costs the patient something. Chasing symmetry with neurotoxin means progressively weakening whichever side is currently stronger, which over successive cycles reduces movement globally rather than balancing it. A patient pursuing symmetry visit after visit ends up with less expression rather than more balance, and the point to make that clear is at the first consultation.
Where an asymmetry is genuinely prominent and genuinely bothersome, the honest framing is that it can be softened, that the improvement will be partial, and that some of its cause may be structural rather than muscular and therefore outside what this treatment addresses.
What changes at the chairside
- Photograph at rest and in animation, both sides, before every first treatment. The animated image is the one with evidential and diagnostic value.
- Record which side is stronger, not just the units given. "Left corrugator pulls harder and further; right brow sits ~2 mm higher at rest" is a note that shortens every future visit.
- Treat asymmetric dosing as normal. Symmetric dosing on an asymmetric face is a decision, and it should be a conscious one.
- Aim short of full correction and review at two weeks. Over-correction lasts longer than the asymmetry it was meant to fix.
- Raise asymmetry once, at consultation, with a demonstration — and resist the temptation to catalogue.
- Separate what is muscular from what is not before promising any degree of improvement.
Assessing and planning around individual variation is the whole of anatomy-led injecting rather than a refinement of it, and it is the substance of Empire's anatomical based aesthetics training and complete facial aesthetic training.
The clinical reasoning above reflects Melissa Pulcini-Buttine's practice as taught in Empire Medical Training's hands-on curriculum. Technique is learned under supervision; this article is educational and is not a substitute for training.
Melissa Pulcini-Buttine, PA is a physician assistant of two decades and has been a professor of anatomy and physiology for approximately fourteen years. She is a faculty member at Empire Medical Training and the founder of an aesthetics practice in Greenwich, Connecticut.
Frequently Asked Questions
How common is baseline facial asymmetry?
Effectively universal. More than 88 percent of people have asymmetric brow positions, and ultrasound of 127 adults found side-to-side differences of up to 40 percent in upper facial muscle thickness and depth, with some muscles reaching 50 percent. Critically, no consistent directional pattern exists, so the asymmetry must be assessed individually rather than assumed.
What are the different types of facial asymmetry an injector should assess?
Three, and they are independent. Position — where structures sit at rest, assessed still and photographed. Morphology — muscle size and depth, which cannot be reliably inspected or palpated and must be inferred. Strength and dynamics — which side pulls harder and further, assessed only on animation, and the only one of the three that neurotoxin acts on directly.
Should dosing be asymmetric?
Frequently, yes. If one side is demonstrably stronger, identical dosing preserves or transforms the asymmetry rather than correcting it. The important constraint is not to chase full correction: an over-treated dominant side stays weak longer than the lighter side, so the asymmetry reappears in the opposite direction as recovery proceeds.
When should asymmetry be raised with the patient?
At consultation, before any treatment, demonstrated in the mirror during animation. Raised afterwards it sounds like an excuse regardless of its accuracy. Name it once, identify the one or two differences relevant to the plan, state the goal as improved balance rather than matched halves, and avoid itemising every asymmetry in the face.
Can neurotoxin correct all facial asymmetry?
No. It acts on muscular, dynamic asymmetry. Asymmetry originating in skeletal structure, differential volume loss or fixed dermal creases does not respond, and no dose adjustment changes that. Establishing which component is muscular before promising improvement is what separates a realistic plan from a disappointed patient.
Disclaimer
This article reflects the clinical opinions and experience of Melissa Pulcini-Buttine, PA, an independent faculty member contributing to Empire Medical Training's curriculum. The views expressed are the author's own and do not necessarily represent those of Empire Medical Training.
It is professional education, not medical advice, and is no substitute for hands-on training or independent clinical judgment. Licensed clinicians remain responsible for their own patient selection, technique and outcomes, for verifying current product labelling, and for practising within their scope and applicable law. Empire Medical Training accepts no liability for reliance on this content.
